{
    "eid": "2-s2.0-85088250706",
    "title": "Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cold agglutinin disease",
        "COVID-19",
        "hemolytic anemia",
        "Mycoplasma pneumoniae",
        "SARS-CoV-2"
    ],
    "authors": [
        "Chatphatai Moonla",
        "Phandee Watanaboonyongcharoen",
        "Gompol Suwanpimolkul",
        "Leilani Paitoonpong",
        "Watsamon Jantarabenjakul",
        "Chantiya Chanswangphuwana",
        "Chantana Polprasert",
        "Ponlapat Rojnuckarin",
        "Opass Putcharoen"
    ],
    "citedby-count": 4,
    "ref-count": 17,
    "ref-list": [
        "Clinical characteristics of coronavirus disease 2019 in China",
        "Rates of co-infection between SARS-CoV-2 and other respiratory pathogens",
        "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
        "Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia",
        "COVID-19 and Mycoplasma pneumoniae coinfection",
        "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
        "Autoimmune hemolytic anemia",
        "Autoimmune haemolytic anaemia associated with COVID-19 infection",
        "Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia",
        "Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia",
        "Increased mean corpuscular hemoglobin concentration: artefact or pathogenical condition?",
        "No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection",
        "Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)",
        "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit",
        "Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State",
        "Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis",
        "Atypical pathogens and challenges in community-acquired pneumonia"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "John Hopkins University School of Medicine, Baltimore",
        "Department of Medicine"
    ]
}